Evidence map›Paper›PMID 40795986›Full record

ArticleJournal of the Royal Society, Interface2025

Mathematical modelling of macrophage and natural killer cell immune response during early stages of peritoneal endometriosis lesion onset.

Claire M Miller, Domenic P J Germano, Alicia M Chenoweth, Sarah Holdsworth-Carson

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Claire M MillerAuckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.ORCID 0000-0003-0758-9447
Domenic P J GermanoSchool of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-5893-4840
Alicia M ChenowethBreast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, London, England, UK.ORCID 0000-0002-2736-9268
Sarah Holdsworth-CarsonJulia Argyrou Endometriosis Centre, Epworth HealthCare, Richmond, Victoria, Australia.

Funding

Aotearoa Foundation
6 · The paper itself

Abstract

The immune system is hypothesized to contribute to the onset of endometriosis lesions. However, the precise mechanisms underlying its role are not yet known. We introduce a novel compartmental model that describes the interactions between innate immune cells, specifically macrophages and natural killer cells, and endometrial cells, occurring within the peritoneal fluid during the early stages of (superficial peritoneal) endometriosis lesion onset. Our study focuses on retrograde influx, immune detection and immune clearance. Results show an increased influx of endometrial cells into peritoneal fluid correlates with heightened pro-inflammatory macrophage activation, but does not lead to an increase in disease. We compare the system's response to changes in immune cytotoxicity and ability to detect ectopic endometrial cells. We predict that reduced cytotoxicity is a key driver of disease. These findings align with the increased immune activation observed clinically. Finally, we predict that an individual can transition to a diseased state following a reduction in immune system cytotoxicity and/or reduced ability to detect ectopic cells. Due to hysteresis, a significant improvement is then required to restore an individual to the disease-free state. This work provides a valuable framework to explore hypotheses of endometriosis lesion onset and assist in understanding of the disease.

Indexed as

EndometriosisEndometriumKiller Cells, NaturalMacrophagesModels, ImmunologicalAscitic FluidFemaleHumanscomputational biologyendometriosisimmune systemmacrophagesmathematical biologynatural killer cells

Identifiers

PMID40795986
PMCPMC12343144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.